Literature DB >> 11517173

Relaxin increases secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 during uterine and cervical growth and remodeling in the pig.

J A Lenhart1, P L Ryan, K M Ohleth, S S Palmer, C A Bagnell.   

Abstract

Matrix metalloproteinases are proteolytic enzymes that degrade the extracellular matrix and are essential for tissue remodeling. Uterine and cervical growth require remodeling of structural barriers to cell invasion and matrix metalloproteinase-2 and -9 degrade type IV collagen, the major component of basement membranes. Relaxin stimulates uterine and cervical growth and remodeling, which includes remodeling of support elements such as basement membranes. The objective of this study was to determine whether relaxin alters the production and/or activity of matrix metalloproteinase-2 and -9 in the uterus or cervix of the pig. The growth-promoting effects of relaxin were elicited by administering relaxin to prepubertal gilts every 6 h for 54 h. The expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 was characterized by gel zymography, and proteins were quantified by immunoblotting. Total enzyme activity was measured using matrix metalloproteinase-specific fluorescent substrate assays. In both uterine and cervical tissues, immunoreactive matrix metalloproteinase-2 and matrix metalloproteinase-9 protein expression was similar in relaxin-treated and control animals. However, tissue-associated gelatinase activity was attenuated by relaxin (P < 0.05). In contrast, relaxin significantly increased the secretion of active matrix metalloproteinase-2 and -9 protein into uterine fluid (P < 0.05). Given the importance of matrix metalloproteinases in extracellular matrix degradation, the observation that relaxin promotes uterine secretion of matrix metalloproteinase-2 and -9 supports the concept that relaxin facilitates the growth and remodeling of reproductive tissues by increasing extracellular proteolysis in the pig reproductive tract.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517173     DOI: 10.1210/endo.142.9.8387

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

Review 1.  New Insights into biological roles of relaxin and relaxin-related peptides.

Authors:  Jae-Il Park; Chia Lin Chang; Sheau Yu Teddy Hsu
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

Review 2.  The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.

Authors:  Jennifer M Sasser
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

3.  Transcriptional Regulation of Connective Tissue Metabolism Genes in Women With Pelvic Organ Prolapse.

Authors:  Ali Borazjani; Nathan Kow; Samantha Harris; Beri Ridgeway; Margot S Damaser
Journal:  Female Pelvic Med Reconstr Surg       Date:  2017 Jan/Feb       Impact factor: 2.091

Review 4.  Cardiovascular effects of relaxin: from basic science to clinical therapy.

Authors:  Xiao-Jun Du; Ross A D Bathgate; Chrishan S Samuel; Anthony M Dart; Roger J Summers
Journal:  Nat Rev Cardiol       Date:  2009-11-24       Impact factor: 32.419

5.  Relaxin stimulates multiple signaling pathways: activation of cAMP, PI3K, and PKCzeta in THP-1 cells.

Authors:  Carmen W Dessauer; Bao T Nguyen
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

6.  Relaxin increases elastase activity and protease inhibitors in smooth muscle cells from the myometrium compared with cells from leiomyomas.

Authors:  Bertha Chen; Yan Wen; Xiao Yun Yu; Mary Lake Polan
Journal:  Fertil Steril       Date:  2008-06-12       Impact factor: 7.329

7.  Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss.

Authors:  Gihan Hashem; Qin Zhang; Takayuki Hayami; Jean Chen; Wei Wang; Sunil Kapila
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

8.  Relaxin's induction of metalloproteinases is associated with the loss of collagen and glycosaminoglycans in synovial joint fibrocartilaginous explants.

Authors:  Tabassum Naqvi; Trang T Duong; Gihan Hashem; Momotoshi Shiga; Qin Zhang; Sunil Kapila
Journal:  Arthritis Res Ther       Date:  2004-10-29       Impact factor: 5.156

9.  Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat.

Authors:  Marcelo Filonzi; Laís C Cardoso; Maristela T Pimenta; Daniel B C Queiróz; Maria C W Avellar; Catarina S Porto; Maria F M Lazari
Journal:  Reprod Biol Endocrinol       Date:  2007-07-10       Impact factor: 5.211

10.  Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates.

Authors:  Richard Ivell; Marga Balvers; Yvonne Pohnke; Ralph Telgmann; Olaf Bartsch; Karin Milde-Langosch; Ana-Maria Bamberger; Almuth Einspanier
Journal:  Reprod Biol Endocrinol       Date:  2003-11-24       Impact factor: 5.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.